Plant-derived PAP proteins fused to immunoglobulin A and M Fc domains induce anti-prostate cancer immune response in mice

키워드

참고문헌 (39)

1. Barve A, "Prostate cancer relevant antigens and enzymes for targeted drug delivery", J Control Release, 187, pp.118~132 (2014)
2. Quintero IB, "Prostatic acid phosphatase is not a prostate specific target", Cancer Res, 67, pp.6549~6554 (2007)
3. 권순석, "Updates on cancer epidemiology in Korea, 2018", 전남의대학술지, 54(2), pp.90~100 (2018), 의과학연구소[DOI]
4. Zhang H, "Current status and future directions of cancer immunotherapy", J Cancer, 9, pp.1773~1781 (2018)
5. Sharma P, "Primary, adaptive, and acquired resistance to cancer immunotherapy", Cell, 168, pp.707~723 (2017)
6. Rius M, "Epigenetic cancer therapy : rationales, targets and drugs", Oncogene, 31, pp.4257~4265 (2012)
7. Petrylak DP, "Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer", N Engl J Med, 351, pp.1513~1520 (2004)
8. Yang C, "Engineering of fc fragments with optimized physicochemical properties implying improvement of clinical potentials for fc-based therapeutics", Front Immunol, 8, pp.1860~ (2018)
9. Czajkowsky DM, "Fcfusion proteins : new developments and future perspectives", EMBO Mol Med, 4, pp.1015~1028 (2012)
10. Korhonen R, "Abatacept, a novel CD80", 86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis, 2009, pp.104, 276~284
11. Cines DB, "Romiplostim", Nat Rev Drug Discov, 7, pp.887~888 (2008)
12. Strober BE, "Alefacept for the treatment of psoriasis and other dermatologic diseases", Dermatol Ther, 20, pp.270~276 (2007)
13. Ammann JU, "Detection of weak receptor-ligand interactions using IgM and J-chain-based fusion proteins", Eur J Immunol, 42, pp.1354~1356 (2012)
14. Nagashima H, "TNF receptor II fusion protein with tandemly repeated Fc domains", J Biochem, 149, pp.337~346 (2011)
15. Mekhaiel DNA, "Polymeric human Fc-fusion proteins with modified effector functions", Sci Rep, 1, pp.124~124 (2011)
16. Heller JE, "Prostatic acid phosphatase : its current clinical status", J Urol, 137, pp.1091~1103 (1987)
17. Guenzi S, "The efficiency of cysteine-mediated intracellular retention determines the differential fate of secretory IgA and IgM in B and plasma cells", Eur J Immunol, 24, pp.2477~2482 (1994)
18. Davis AC, "On the structure of polymeric IgM", Eur J Immunol, 18, pp.1001~1008 (1988)
19. Lim Chae-Yeon, "Immune Responses to Plant-Derived Recombinant Colorectal Cancer Glycoprotein EpCAM-FcK Fusion Protein in Mice", Biomolecules & Therapeutics, 30(6), pp.546~552 (2022), 한국응용약물학회[DOI]
20. 송일찬, "Expression and in vitro function of anti-cancer mAbs in transgenic Arabidopsis thaliana", BMB Reports, 53(4), pp.229~233 (2020), 생화학분자생물학회[DOI]
21. Kim DS, "A plant-derived antigen-antibody complex induces anti-cancer immune responses by forming a large quaternary structure", Int J Mol Sci, 21, pp.1~18 (2020)
22. Song I, "Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody(mAb)CO17-1A affects mAb expression and plant stress response", PloS One, 13, pp.e0198978~ (2018)
23. Fischer R, "Towards molecular farming in the future : transient protein expression in plants", Biotechnol Appl Biochem, 30(Pt 2), pp.113~116 (1999)
24. Fischer R, "Towards molecular farming in the future : moving from diagnostic protein and antibody production in microbes to plants", Biotechnol Appl Biochem, 30(Pt 2), pp.101~108 (1999)
25. Shanmugaraj BM, "Plant expression platform for the production of recombinant pharmaceutical proteins", Austin J Biotechnol Bioeng, 1, pp.4~ (2014)
26. Horn M, "Plant molecular farming : systems and products", Plant Cell Rep, 22, pp.711~720 (2004)
27. Twyman RM, "Molecular farming in plants : host systems and expression technology", Trends Biotechnol, 21, pp.570~578 (2003)
28. Lim CY, "Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants", Front Plant Sci, 5, pp.778~ (2015)
29. Lu Z, "Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants", Biomed Res Int, 2012, pp.364240~ (2012)
30. Schouten A, "The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco", Plant Mol Biol, 30, pp.781~793 (1996)
31. Wandelt CI, "Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants", Plant J, 2, pp.181~192 (1992)
32. Schroeder HW Jr, "Structure and function of immunoglobulins", J Allergy Clin Immunol, 125, pp.S41~S52 (2010)
33. Sorensen V, "Polymerization of IgA and IgM : roles of Cys309", Cys414 and the secretory tailpiece, 1999, pp.162, 3448~3455
34. Normansell DE, "Human immunoglobulin subclasses", Diagn Clin Immunol, 5, pp.115~128 (1987)
35. Kartikasari AER, "Therapeutic cancer vaccines-T cell responses and epigenetic modulation", Front Immunol, 9, pp.3109~ (2019)
36. Westdorp H, "Immunotherapy for prostate cancer : lessons from responses to tumor-associated antigens", Front Immunol, 5, pp.191~ (2014)
37. Melssen M, "Vaccines targeting helper T cells for cancer immunotherapy", Curr Opin Immunol, 47, pp.85~92 (2017)
38. GRGina R. Webster, "A polymeric immunoglobulin-antigen fusion protein strategy for enhancing vaccine immunogenicity", Plant Biotechnol J, 16, pp.1983~1996 (2018)
39. Shanmugaraj B, "Plant molecular farming : a viable platform for recombinant biopharmaceutical production", Plants, 9, pp.842~ (2020)

관련 논문AI추천